Life Sciences Law

Life Sciences is a complex, heavily regulated industry which covers everything from research and development to manufacturing, to marketing and sale, and including analyses of sector specific IP and data protection issues.

Your challenge:

Life science is a heavily regulated territory where practitioners must navigate through complex laws, regulations, and guidelines. The time needed to adequately research and understand the prevailing legal framework can be substantial. This is often undertaken without a scientific technical background.
Life sciences products and lifecycles, and pipeline are crucial to commercial success and run over many years. It’s essential to associate the appropriate regulatory, political, economic and legal framework to every stage of the lifecycle to maximise return. How do you reconcile the tension between completing legal and technical research, efficiency, accuracy, and speed?

How we can help:

The LexisPSL Life Sciences module is a bespoke solution which combines practical guidance, legislation, current awareness and the latest news from multiple practice areas into one place. We provide intuitive access to trusted relevant sources and content so that you can find the answers to your questions quickly.

Life Sciences News

Access this content free for 7 days with a trial of LexisPSL.

Get started with Life Sciences products and solutions

What's new in Life Sciences Law

Sample Title

The following features and improvements were added in July 2018 

  • Continued aggressive build and addition of new content, including:
    • New Practice Note on the implications of Brexit in the Life Sciences sector.
    • New Practice Note and training materials on the reform of the medical device’s regulatory framework.
    • New Practice Note on the reform of the clinical trials regulatory framework and the new Clinical Trials Regulation.
    • New Practice Note on tax considerations for the life sciences sector.
    • New suite of new starter guides aimed at trainees or anyone new to the sector.
    • New training materials on interactions with healthcare professionals.
    • New Practice Note on access to documents and freedom of information requests in the life sciences sector (includes review of recent case law regarding the EMA’s disclosure of clinical trial documents policy).
    • New Precedent due diligence questionnaires for use in M&A transactions involving pharmaceutical and medical device companies.
    • New Practice Note on M&A in the life sciences sector.
    • Creation of life sciences clauses bank with life sciences definitions (more to come).
    • New Practice Note on the regulation of E-Cigarettes.